These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6984640)

  • 21. Subpopulations of human T lymphocytes. IX. Imbalance of T cell subpopulations in patients with progressive systemic sclerosis.
    Gupta S; Malaviya AN; Rajagopalan P; Good RA
    Clin Exp Immunol; 1979 Nov; 38(2):342-7. PubMed ID: 316754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Characteristics of cellular and humoral immunity in patients with systemic scleroderma].
    Iashchenko OB
    Vrach Delo; 1983 Feb; (2):61-4. PubMed ID: 6601883
    [No Abstract]   [Full Text] [Related]  

  • 23. Is systemic sclerosis an antigen-driven T cell disease?
    Sakkas LI; Platsoucas CD
    Arthritis Rheum; 2004 Jun; 50(6):1721-33. PubMed ID: 15188347
    [No Abstract]   [Full Text] [Related]  

  • 24. Abnormalities of T lymphocyte subsets in patients with progressive systemic sclerosis (PSS, scleroderma).
    Inoshita T; Whiteside TL; Rodnan GP; Taylor FH
    J Lab Clin Med; 1981 Feb; 97(2):264-77. PubMed ID: 6450255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis of progressive systemic sclerosis.
    Haustein UF; Herrmann K; Böhme HJ
    Int J Dermatol; 1986 Jun; 25(5):286-93. PubMed ID: 3522447
    [No Abstract]   [Full Text] [Related]  

  • 26. Peripheral blood lymphocyte distribution in scleroderma.
    Carapeto FJ; Winkelmann RK
    Dermatologica; 1975; 151(4):228-35. PubMed ID: 773715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandin E1 in systemic sclerosis.
    Biltz H; Küster W; Lüders G; Wehrmann W; Ammari B; Kreysel HW
    Prog Clin Biol Res; 1989; 301():469-73. PubMed ID: 2571994
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of cutaneous sclerosis and aplastic anemia with antithymocyte globulin.
    Balaban EP; Sheehan RG; Lipsky PE; Frenkel EP
    Ann Intern Med; 1987 Jan; 106(1):56-8. PubMed ID: 3491559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating T and B lymphocytes in progressive systemic sclerosis.
    de Jesus DG; Clancy RL
    J Rheumatol; 1975 Sep; 2(3):336-9. PubMed ID: 1081143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and function of surface antigens on scleroderma fibroblasts.
    Abraham D; Lupoli S; McWhirter A; Plater-Zyberk C; Piela TH; Korn JH; Olsen I; Black C
    Arthritis Rheum; 1991 Sep; 34(9):1164-72. PubMed ID: 1718289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In vitro reactivity of lymphocytes obtained from patients with diffuse scleroderma].
    Onisk Z; Tchórzewski H
    Przegl Dermatol; 1975; 62(2):183-6. PubMed ID: 1079955
    [No Abstract]   [Full Text] [Related]  

  • 32. Peripheral T cells from patients with early systemic sclerosis kill autologous fibroblasts in co-culture: is T-cell response aimed to play a protective role?
    De Palma R; D'Aiuto E; Vettori S; Cuoppolo P; Abbate G; Valentini G
    Rheumatology (Oxford); 2010 Jul; 49(7):1257-66. PubMed ID: 20418226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of the laboratory in rheumatology. Lymphocytes.
    Russell AS; Edelman J
    Clin Rheum Dis; 1983 Apr; 9(1):117-34. PubMed ID: 6603321
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of D-penicillamine on the T cell phenotype in scleroderma. Comparison between treated and untreated patients.
    Rosada M; Fiocco U; De Silvestro G; Doria A; Cozzi L; Favaretto M; Todesco S
    Clin Exp Rheumatol; 1993; 11(2):143-8. PubMed ID: 7685256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunology of systemic sclerosis.
    Artlett CM
    Front Biosci; 2005 May; 10():1707-19. PubMed ID: 15769660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.
    Arahata K; Engel AG
    Ann Neurol; 1984 Aug; 16(2):193-208. PubMed ID: 6383191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unusual case of progressive systemic sclerosis with onset in early childhood and following infectious mononucleosis.
    Urano J; Kohno H; Watanabe T
    Eur J Pediatr; 1981 Jul; 136(3):285-9. PubMed ID: 6973466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormalities of T lymphocyte subsets in systemic sclerosis demonstrated with anti-CD45RA and anti-CD29 monoclonal antibodies.
    Kahan A; Kahan A; Picard F; Menkès CJ; Amor B
    Ann Rheum Dis; 1991 Jun; 50(6):354-8. PubMed ID: 1711833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Humoral and cellular immunity in progressive systemic sclerosis.
    Sierakowski S; Bernacka K
    Med Interne; 1987; 25(4):233-8. PubMed ID: 3501150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Quantitative evaluation of T-, B- and 0-lymphocyte populations in focal scleroderma].
    Fedorova EG
    Vestn Dermatol Venerol; 1980 Jun; (6):17-9. PubMed ID: 6967244
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.